Dowson Andrew

Summary

Affiliation: King's College Hospital
Country: UK

Publications

  1. pmc Diagnosing migraine in research and clinical settings: the validation of the Structured Migraine Interview (SMI)
    Zainab Samaan
    Dept of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    BMC Neurol 10:7. 2010
  2. pmc Managing migraine headaches experienced by patients who self-report with menstrually related migraine: a prospective, placebo-controlled study with oral sumatriptan
    Andrew J Dowson
    The King s Headache Service, King s College Hospital, Denmark Hill, London SE5 9RS, UK
    J Headache Pain 6:81-7. 2005
  3. ncbi request reprint Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting
    Andrew J Dowson
    King s College Headache Service, King s College Hospital, London, UK
    Drugs R D 9:147-58. 2008
  4. pmc Patients' preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraine
    Andrew J Dowson
    King s Headache Service, King s College Hospital, Denmark Hill, London SE5 9RS, UK
    J Headache Pain 6:112-20. 2005
  5. ncbi request reprint Part III: the convenience of, and patient preference for, zolmitriptan orally disintegrating tablet
    Andrew J Dowson
    The King s Headache Services, King s College Hospital, London, UK
    Curr Med Res Opin 21:S13-7. 2005
  6. ncbi request reprint Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire
    A J Dowson
    The King s Headache Service, King s College Hospital, Denmark Hill, London SE5 9RS, UK
    Neurol Sci 25:S276-8. 2004
  7. pmc How do patients referred to neurologists for headache differ from those managed in primary care?
    Leone Ridsdale
    Department of General Practice and Primary Care, Institute of Psychiatry, London, UK
    Br J Gen Pract 57:388-95. 2007
  8. ncbi request reprint Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial
    Andrew J Dowson
    The King s Headache Services, King s College Hospital, London, UK
    CNS Drugs 17:839-51. 2003
  9. pmc Service use and costs for people with headache: a UK primary care study
    Paul McCrone
    P024, Health Service and Population Research Department, Institute of Psychiatry, King s College London, De Crespigny Park, London, SE5 8AF, UK
    J Headache Pain 12:617-23. 2011
  10. ncbi request reprint Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial
    Andrew J Dowson
    King s Headache Services, King s College Hospital, London, UK
    Headache 45:17-24. 2005

Detail Information

Publications22

  1. pmc Diagnosing migraine in research and clinical settings: the validation of the Structured Migraine Interview (SMI)
    Zainab Samaan
    Dept of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada
    BMC Neurol 10:7. 2010
    ..The aim of this study was to design a short and practical screening tool to identify migraine for clinical and research purposes...
  2. pmc Managing migraine headaches experienced by patients who self-report with menstrually related migraine: a prospective, placebo-controlled study with oral sumatriptan
    Andrew J Dowson
    The King s Headache Service, King s College Hospital, Denmark Hill, London SE5 9RS, UK
    J Headache Pain 6:81-7. 2005
    ..007) and outside (79% vs. 31%, p<0.001) the menstrual period. Sumatriptan was generally well tolerated. Oral sumatriptan (100 mg) is an effective and well tolerated acute treatment for patients who report menstrually related migraine...
  3. ncbi request reprint Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting
    Andrew J Dowson
    King s College Headache Service, King s College Hospital, London, UK
    Drugs R D 9:147-58. 2008
    ..This study investigated the clinical profile of botulinum toxin A in a naturalistic clinical practice setting in a population of patients with cervical dystonia associated with chronic headache and a history of migraine...
  4. pmc Patients' preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraine
    Andrew J Dowson
    King s Headache Service, King s College Hospital, Denmark Hill, London SE5 9RS, UK
    J Headache Pain 6:112-20. 2005
    ..Patient preference is a sensitive clinical trial endpoint and physicians should consider using it when reviewing the efficacy of acute migraine medications...
  5. ncbi request reprint Part III: the convenience of, and patient preference for, zolmitriptan orally disintegrating tablet
    Andrew J Dowson
    The King s Headache Services, King s College Hospital, London, UK
    Curr Med Res Opin 21:S13-7. 2005
    ....
  6. ncbi request reprint Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire
    A J Dowson
    The King s Headache Service, King s College Hospital, Denmark Hill, London SE5 9RS, UK
    Neurol Sci 25:S276-8. 2004
    ....
  7. pmc How do patients referred to neurologists for headache differ from those managed in primary care?
    Leone Ridsdale
    Department of General Practice and Primary Care, Institute of Psychiatry, London, UK
    Br J Gen Pract 57:388-95. 2007
    ..Headache is the neurological symptom most frequently presented to GPs and referred to neurologists, but little is known about how referred patients differ from patients managed by GPs...
  8. ncbi request reprint Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial
    Andrew J Dowson
    The King s Headache Services, King s College Hospital, London, UK
    CNS Drugs 17:839-51. 2003
    ..To primarily assess the tolerability of zolmitriptan (Zomig) nasal spray 5mg in the long-term treatment of migraine, as well as determine efficacy and consistency of effect over time (up to 1 year)...
  9. pmc Service use and costs for people with headache: a UK primary care study
    Paul McCrone
    P024, Health Service and Population Research Department, Institute of Psychiatry, King s College London, De Crespigny Park, London, SE5 8AF, UK
    J Headache Pain 12:617-23. 2011
    ..8 billion including lost employment. These are likely to be underestimates because many people experiencing headaches do not consult their GP...
  10. ncbi request reprint Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial
    Andrew J Dowson
    King s Headache Services, King s College Hospital, London, UK
    Headache 45:17-24. 2005
    ....
  11. ncbi request reprint Oral almotriptan: practical uses in the acute treatment of migraine
    Andrew J Dowson
    The King s Headache Service, King s College Hospital, Denmark Hill, London, SE5 9RS, UK
    Expert Rev Neurother 4:339-48. 2004
    ..Meta-analyses and post hoc analyses of clinical data confirm these findings. In conclusion, almotriptan 12.5 mg is a good therapeutic choice for the symptomatic treatment of acute migraine attacks...
  12. ncbi request reprint Disability associated with headaches occurring inside and outside the menstrual period in those with migraine: a general practice study
    Andrew J Dowson
    King s Headache Service, King s College Hospital, London, UK
    Headache 45:274-82. 2005
    ..This study investigated the disability of females who have migraine and other headache attacks occurring during and outside the menstrual period...
  13. ncbi request reprint Analysis of the patients attending a specialist UK headache clinic over a 3-year period
    Andrew J Dowson
    King s Headache Service, King s College Hospital, London, UK
    Headache 43:14-8. 2003
    ..This study analyzed the profile of patients who attended a specialist UK headache clinic over a 3-year period...
  14. ncbi request reprint Review of zolmitriptan and its clinical applications in migraine
    Andrew J Dowson
    Director, Kings Headache Services, Kings College Hospital, Denmark Hill, London, UK
    Expert Opin Pharmacother 3:993-1005. 2002
    ..The consistent efficacy in treating all types of migraine and the choice of available formulations make zolmitriptan acceptable to patients and a suitable first-line therapy for the treatment of migraine...
  15. ncbi request reprint Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis
    Andrew J Dowson
    King s Headache Service, King s College Hospital, London, UK
    CNS Drugs 19:483-97. 2005
    ..The quality of the clinical evidence on MOH is suboptimal and further biological and clinical research is urgently required to help facilitate the management of these patients more effectively in the future...
  16. pmc Headache: a 'suitable case' for behavioural treatment in primary care?
    Emmanouil K Symvoulakis
    Department of General Practice and Primary Care, King s College, London, UK
    Br J Gen Pract 57:231-7. 2007
    ..The large population seen in general practice, most of whom have uncomplicated primary headaches, could represent the ideal target for testing behavioural therapies...
  17. ncbi request reprint Sumatriptan fast-disintegrating/rapid-release tablets: viewpoints
    Hans A Carpay
    Department of Neurology, Hospital Gooi Noord, Laren, The Netherlands
    Drugs 66:891-2. 2006
  18. ncbi request reprint Part II: clinical efficacy and tolerability of zolmitriptan orally disintegrating tablet in the acute treatment of migraine
    Elizabeth W Loder
    Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA 02114, USA
    Curr Med Res Opin 21:S8-12. 2005
    ..Adverse events observed with zolmitriptan ODT were similar to those associated with the serotonin1B/1D agonists as a class, and were generally transient and of mild or moderate intensity...
  19. ncbi request reprint Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet
    Bruce R Charlesworth
    AstraZeneca, Macclesfield, England
    CNS Drugs 17:653-67. 2003
    ..The objective of this study was to compare the efficacy and tolerability of fixed doses of zolmitriptan administered via a nasal spray with placebo and zolmitriptan oral tablet in the acute treatment of migraine...
  20. ncbi request reprint How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials
    Carl G H Dahlöf
    Gothenburg Migraine Clinic, Sociala Huset, Sweden
    Headache 42:99-113. 2002
    ..In conclusion, almotriptan's consistent pharmacokinetics and good efficacy, in combination with excellent tolerability, make it an attractive choice in the acute treatment of migraine attacks...
  21. ncbi request reprint Reliability, validity, and clinical utility of the Migraine-ACT questionnaire
    Shaun G Kilminster
    Institute of Naval Medicine, Alverstoke, Hampshire, UK
    Headache 46:553-62. 2006
    ..It has been shown to be easy to use, and to be reliable and accurate in its assessments...
  22. ncbi request reprint Casebook: headache
    Andrew J Dowson
    King s Headache Service, King s College Hospital
    Practitioner 247:45-52. 2003
    ..Patients undergoing the correct management should generally see a massive improvement in their quality of life. Headache can, therefore, be a very satisfying condition for the clinician to treat...